|
|
PhenoPath Pathology/Immunohistochemistry Conference
PhenoPath Laboratories periodically hosts evening pathology/immunohistochemistry conferences at our facility in the Fremont neighborhood of Seattle. These provide a venue where Seattle-area pathologists can meet regularly on an informal basis, share interesting cases, and learn from each other. The format of the conference is a Social Hour beginning at 6:30 pm, followed by a lecture by an invited speaker at 7:30 pm and concluding with interesting case presentations. See our Contact Us page for directions to PhenoPath.
Conference Speakers 2011
- February 3, 2011
Anais Malpica, MD,
Chief, Section of Gynecologic Pathology; Director, Gynecologic Pathology Fellowship Program; Professor, Dept. of Pathology, University of Texas, M.D. Anderson Cancer Center
Mucinous Tumors in the Ovary, an Update
- May 25, 2011 - Hosted by Genentech
Allen M. Gown, MD, Medical Director and Chief Pathologist, PhenoPath Laboratories, PLLC
Quality HER2 Testing: Impacting Breast and Metastatic Gastric Cancer Treatment Decisions
- June 2, 2011
Adam Bagg, MB, BCh, Dept. of Pathology & Laboratory Medicine,
Hospital of the University of Pennsylvania
Rational Use of Genetic Analysis in Lymphomas
- September 15, 2011
Pedram Argani, MD, Director, Breast Pathology Service, Professor of Pathology, Johns Hopkins University School of Medicine
Translocation Carcinomas of the Kidney
- December 14, 2011 - Hosted by Genentech
Allen M. Gown, MD, Medical Director and Chief Pathologist, PhenoPath Laboratories, PLLC
Quality HER2 Testing: Impacting Breast and Metastatic Gastric Cancer Treatment Decisions
Conference Speakers 2012
- February 16, 2012
Matt van de Rijn, MD, PhD, Professor, Dept. of Pathology, Stanford University Medical Center
Gene expression profiling studies leading to novel diagnostic markers in sarcomas
- May 3, 2012
Blake Gilks, MD, FRCPC, Professor, Dept. of Pathology & Laboratory Medicine, University of British Columbia; VGH, Anatomical Pathology Site Director
Ovarian surface epithelial carcinomas: importance of accurate subtype diagnosis
|
